Author:
Sullivan Harold C.,Fisher Kevin E.,Hoffa Anne L.,Wang Jason,Saxe Debra,Siddiqui Momin T.,Cohen Cynthia
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Medical Laboratory Technology,Histology,Pathology and Forensic Medicine
Reference25 articles.
1. EML4-ALK fusion gene in patients with lung carcinoma: biology, diagnostics and targeted therapy.;Vasikova;Klin Onkol,2012
2. Crizotinib, a small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases.;Rodig;Curr Opin Investig Drugs,2010
3. . Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer.;Lee;Lung Cancer,2013
4. . Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.;Takeuchi;Clin Cancer Res,2008
5. . A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer.;Soda;Clin Cancer Res,2012
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献